Genome-scale modeling and in silico analysis of mouse cell metabolic network.

Genome-scale metabolic modeling has been successfully applied to a multitude of microbial systems, thus improving our understanding of their cellular metabolisms. Nevertheless, only a handful of works have been done for describing mammalian cells, particularly mouse, which is one of the important model organisms, providing various opportunities for both biomedical research and biotechnological applications. Presented herein is a genome-scale mouse metabolic model that was systematically reconstructed by improving and expanding the previous generic model based on integrated biochemical and genomic data of Mus musculus. The key features of the updated model include additional information on gene-protein-reaction association, and improved network connectivity through lipid, amino acid, carbohydrate and nucleotide biosynthetic pathways. After examining the model predictability both quantitatively and qualitatively using constraints-based flux analysis, the structural and functional characteristics of the mouse metabolism were investigated by evaluating network statistics/centrality, gene/metabolite essentiality and their correlation. The results revealed that overall mouse metabolic network is topologically dominated by highly connected and bridging metabolites, and functionally by lipid metabolism that most of essential genes and metabolites are from. The current in silico mouse model can be exploited for understanding and characterizing the cellular physiology, identifying potential cell engineering targets for the enhanced production of recombinant proteins and developing diseased state models for drug targeting.

[1]  I. Karimi,et al.  Characterizing Escherichia coli DH5α growth and metabolism in a complex medium using genome‐scale flux analysis , 2009, Biotechnology and bioengineering.

[2]  Sang Yup Lee,et al.  MetaFluxNet: the management of metabolic reaction information and quantitative metabolic flux analysis , 2003, Bioinform..

[3]  R. Sasaki,et al.  Phthalate esters enhance quinolinate production by inhibiting α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD), a key enzyme of the tryptophan pathway , 2004 .

[4]  M. Moo-young,et al.  Statistical methods in media optimization for batch and fed-batch animal cell culture , 2007, Bioprocess and biosystems engineering.

[5]  Markus J. Herrgård,et al.  Integrating high-throughput and computational data elucidates bacterial networks , 2004, Nature.

[6]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[7]  Markus J. Herrgård,et al.  Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. , 2004, Genome research.

[8]  G. Church,et al.  Analysis of optimality in natural and perturbed metabolic networks , 2002 .

[9]  B. Palsson,et al.  How will bioinformatics influence metabolic engineering? , 1998, Biotechnology and bioengineering.

[10]  M. Betenbaugh,et al.  A mathematical model of N-linked glycosylation. , 2005, Biotechnology and bioengineering.

[11]  A. Burgard,et al.  Optknock: A bilevel programming framework for identifying gene knockout strategies for microbial strain optimization , 2003, Biotechnology and bioengineering.

[12]  W. Lennarz,et al.  Unraveling the Mechanism of Protein N-Glycosylation* , 2005, Journal of Biological Chemistry.

[13]  Sang Yup Lee,et al.  Metabolite essentiality elucidates robustness of Escherichia coli metabolism , 2007, Proceedings of the National Academy of Sciences.

[14]  David C James,et al.  Systems biotechnology of mammalian cell factories. , 2008, Briefings in functional genomics & proteomics.

[15]  B. Palsson,et al.  Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110 , 1994, Applied and environmental microbiology.

[16]  Dave Siak-Wei Ow,et al.  Identification of cellular objective for elucidating the physiological state of plasmid‐bearing Escherichia coli using genome‐scale in silico analysis , 2009, Biotechnology progress.

[17]  R. Bergeron,et al.  Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation. , 1983, Science.

[18]  A. Dove The bittersweet promise of glycobiology , 2001, Nature Biotechnology.

[19]  D. Kell Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[20]  G. Church,et al.  Genome-Scale Metabolic Model of Helicobacter pylori 26695 , 2002, Journal of bacteriology.

[21]  B O Palsson,et al.  Metabolic modeling of microbial strains in silico. , 2001, Trends in biochemical sciences.

[22]  A. Pegg,et al.  Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to 1,3-bis-(2-chloroethyl)-N-nitrosourea. , 2000, The Biochemical journal.

[23]  H. Sasano,et al.  Abnormal uterus with polycysts, accumulation of uterine prostaglandins, and reduced fertility in mice heterozygous for acyl-CoA synthetase 4 deficiency. , 2001, Biochemical and biophysical research communications.

[24]  A. Levchenko,et al.  The Systems Biology of Glycosylation , 2004, Chembiochem : a European journal of chemical biology.

[25]  Brigitte Gasser,et al.  Yeast systems biotechnology for the production of heterologous proteins. , 2009, FEMS yeast research.

[26]  Janice M. Reichert,et al.  Development trends for monoclonal antibody cancer therapeutics , 2007, Nature Reviews Drug Discovery.

[27]  L. Nielsen,et al.  Modeling Hybridoma Cell Metabolism Using a Generic Genome‐Scale Metabolic Model of Mus musculus , 2008, Biotechnology progress.

[28]  Jens Nielsen,et al.  Impact of systems biology on metabolic engineering of Saccharomyces cerevisiae. , 2008, FEMS yeast research.

[29]  Markus J. Herrgård,et al.  Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.

[30]  Adam M. Feist,et al.  The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli , 2008, Nature Biotechnology.

[31]  K. Yamamoto,et al.  Amino acid and vitamin requirements in mammalian cultured cells , 1993, Amino Acids.

[32]  I. Karimi,et al.  Elucidation of metabolism in hybridoma cells grown in fed‐batch culture by genome‐scale modeling , 2009, Biotechnology and bioengineering.

[33]  B. Fleischer Mechanism of glycosylation in the Golgi apparatus. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  E. Davidov,et al.  Advancing drug discovery through systems biology. , 2003, Drug discovery today.

[35]  A. Schousboe,et al.  Evaluation of the importance of transamination versus deamination in astrocytic metabolism of [U‐ 13C] glutamate , 1996, Glia.

[36]  M. Dauner,et al.  Metabolic flux model for an anchorage‐dependent MDCK cell line: Characteristic growth phases and minimum substrate consumption flux distribution , 2008, Biotechnology and bioengineering.

[37]  Wei-Shou Hu,et al.  Large scale gene expression profiling of metabolic shift of mammalian cells in culture. , 2004, Journal of biotechnology.

[38]  M. Wenk The emerging field of lipidomics , 2005, Nature Reviews Drug Discovery.

[39]  B. Palsson,et al.  Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.

[40]  Jens Nielsen,et al.  Can yeast systems biology contribute to the understanding of human disease? , 2008, Trends in biotechnology.

[41]  M. Reff High-level production of recombinant immunoglobulins in mammalian cells. , 1993, Current opinion in biotechnology.

[42]  Sang Yup Lee,et al.  Systems biotechnology for strain improvement. , 2005, Trends in biotechnology.

[43]  Dongxiao Zhu,et al.  BMC Bioinformatics BioMed Central , 2005 .

[44]  M. Yaspo Taking a functional genomics approach in molecular medicine. , 2001, Trends in molecular medicine.

[45]  Z. Kovačević,et al.  Mitochondrial metabolism of glutamine and glutamate and its physiological significance. , 1983, Physiological reviews.

[46]  C. Schilling,et al.  Use of constraint-based modeling for the prediction and validation of antimicrobial targets. , 2006, Biochemical pharmacology.

[47]  V. Schachter,et al.  Genome-scale models of bacterial metabolism: reconstruction and applications , 2008, FEMS microbiology reviews.

[48]  Gang Liu,et al.  Systems-level modeling of cellular glycosylation reaction networks: O-linked glycan formation on natural selectin ligands , 2008, Bioinform..

[49]  Y. Hayashizaki,et al.  Comprehensive analysis of the mouse metabolome based on the transcriptome. , 2003, Genome research.

[50]  Satoru Kawai,et al.  An Algorithm for Drawing General Undirected Graphs , 1989, Inf. Process. Lett..

[51]  Carsten Peterson,et al.  Random Boolean network models and the yeast transcriptional network , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Palsson,et al.  Metabolic modelling of microbes: the flux-balance approach. , 2002, Environmental microbiology.

[53]  Kiran Raosaheb Patil,et al.  Use of genome-scale microbial models for metabolic engineering. , 2004, Current opinion in biotechnology.

[54]  B. Palsson,et al.  Towards multidimensional genome annotation , 2006, Nature Reviews Genetics.

[55]  D. Ramkrishna,et al.  Mathematical models of metabolic pathways. , 1999, Current opinion in biotechnology.

[56]  An-Ping Zeng,et al.  Reconstruction of metabolic networks from genome data and analysis of their global structure for various organisms , 2003, Bioinform..